Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Recognize the warning signs of a bad investment to protect your finances. Stay informed and make sound investment decisions.
18,453 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Could SpaceX stock reach $192 by 2027? This guide lays out the drivers, the math behind the target, and realistic ste...
A veteran fund manager challenges Wall Street's reliance on earnings when valuing AI plays, arguing that the E in P/E...
In markets juggling record highs with recession fears, a few billionaire investors are doubling down on the backbone ...
A single metric may reveal whether Nvidia will continue dominate in AI. This deep dive explains the number, the risks...
Dell fell about 6% as memory costs squeezed margins, while Western Digital rose around 5% on continued AI-driven dema...
In seven days, five senior Google AI researchers resigned, fueling concerns that Alphabet is losing its AI edge. The ...
JPMorgan Chase just paired a 10% dividend hike with a $50 billion buyback after clearing the Fed's stress test. Here'...
A leading analyst has reiterated a $250 SpaceX target, arguing that SpaceX's physical AI capabilities could reshape r...
Cape Verde's Vozinha has surged to a $17 million valuation as World Cup spotlight boosts a small nation’s brand. Inve...
A seasoned financial writer explains how a president-defining stance from the new Fed chair can ripple through stocks...
The Federal Reserve’s annual stress tests show 32 large banks surviving a severe unemployment shock, with capital cus...